Christina M. Danley, OD, FOVDR, explores the many nuances that require consideration when answering a common question asked by parents of children with myopia.
|Videos|September 13, 2021
Podcast: Amanda Nanasy, OD, discusses NFL sports vision, concussions
Advertisement
Dr. Amanda Nanasy, OD, team optometrist for the Miami Dolphins and director of the Florida Institute of Sports Vision joins Open Your Eyes host, Kerry Gelb, OD, for a discussion on concussion and eye care. She is focused on improving the profession of sports vision by developing new strategies and procedures.
Advertisement
Related to this article
Kevin Chan, OD, MS, discusses an AAOpt 2026 symposium on individualized low-dose atropine dosing for myopia and the FDA outlook ahead of the SYD-101 advisory meeting.
Raman Bhakhri, OD, FAAO, alongside Xiao Yu, OD, FAAO, discussed emerging investigational therapies for the disease during their AAOpt 2026 session.
A single Epioxa epi-on cross-linking treatment sustained a 1.9 D Kmax improvement through three years in keratoconus, with no serious adverse events reported.
Jamie Kuzniar, OD, FAAO, FSLS, discusses a case-based AAOpt 2026 session on scleral lens complications, fitting around cross-linking, and advice for new graduates.
IDOC's 2025 benchmarks from 175-plus independent OD practices put median practice net at 31% of revenue as variable costs fell for the first time since tracking began.
Magdalena Stec, OD, FAAO; Noreen Shaikh, OD, FAAO; Huizi Kelly Yin, OD, FAAO; and Brenda Bohnsack, MD, PhD, detail their AAOpt 2026 session in Anaheim, California.
Kwaku Osei, OD, PhD, FAAO, discussed patient-reported outcomes with a senofilcon C (Johnson & Johnson; Acuvue Vita), reusable lens, with the majority of wearers rating comfort, vision, and handling favorably.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
AAOpt 2026: Understanding the gene therapy landscape for retinitis pigmentosa
2
Epioxa epi-on cross-linking holds keratoconus gains at 3 years
3
AAOpt 2026: Evaluating the comfort and usability of Acuvue Vita contact lenses
4
Independent OD practices net 31% of revenue, IDOC benchmarks show
5